Joseph J. Gemmete

ORCID: 0000-0003-2760-3613
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Intracranial Aneurysms: Treatment and Complications
  • Vascular Malformations Diagnosis and Treatment
  • Cerebrovascular and Carotid Artery Diseases
  • Acute Ischemic Stroke Management
  • Vascular Malformations and Hemangiomas
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Venous Thromboembolism Diagnosis and Management
  • Neurosurgical Procedures and Complications
  • Central Venous Catheters and Hemodialysis
  • Vascular Procedures and Complications
  • Lymphatic Disorders and Treatments
  • Head and Neck Surgical Oncology
  • Radiation Dose and Imaging
  • Meningioma and schwannoma management
  • Spinal Fractures and Fixation Techniques
  • Moyamoya disease diagnosis and treatment
  • Gastrointestinal disorders and treatments
  • Cerebral Venous Sinus Thrombosis
  • Gallbladder and Bile Duct Disorders
  • Esophageal and GI Pathology
  • Peripheral Artery Disease Management
  • Aortic aneurysm repair treatments
  • Renal and Vascular Pathologies
  • Advanced Radiotherapy Techniques

University of Michigan
2016-2025

Gentherm (United States)
2025

Michigan Medicine
2015-2024

Michigan United
2014-2021

University Health System
2013-2021

Oxford University Press (United Kingdom)
2018-2020

Ann Arbor VA Medical Center
2020

Northwestern Medicine
2019

University of Colorado Denver
2017

Inova Alexandria Hospital
2017

PURPOSE: To assess the use of nonstandard, variable window width and level review settings in computed tomography (CT) without contrast material administration detection acute stroke. MATERIALS AND METHODS: Nonenhanced CT was performed 21 patients with (<6 hours) middle cerebral arterial stroke nine control patients. Two blinded neuroradiologists rated all scans for presence parenchymal hypoattenuation. Images were reviewed at a picture archiving communication system (PACS) workstation,...

10.1148/radiology.213.1.r99oc10150 article EN Radiology 1999-10-01

Lesion volume is often used as an end point in clinical trials of oncology therapy. We sought to compare the common method using orthogonal diameters estimate lesion (the diameter method) with a computer-assisted planimetric technique perimeter method).Radiologists reviewed 825 magnetic resonance imaging studies from 219 patients glioblastoma multiforme. Each study had independently estimated via and methods. Cystic areas were subtracted out or excluded outlined lesion. Inter- intrareader...

10.1200/jco.2001.19.2.551 article EN Journal of Clinical Oncology 2001-01-15

This study was undertaken to define the age-related prevalence of cavernous malformations (CMs) in children and young adults undergoing intracranial imaging. In addition, authors aim clarify natural history CMs people, especially those with incidentally discovered lesions.To identify patients CMs, retrospectively reviewed electronic medical records 14,936 consecutive 25 years age or younger who had undergone brain MR a CM, clinical imaging data were collected. Patients untreated cavernomas...

10.3171/2011.11.peds11390 article EN Journal of Neurosurgery Pediatrics 2012-02-01

10.1007/s11940-009-0051-3 article EN Current Treatment Options in Neurology 2010-01-01

High-volume centers have better outcomes than low-volume when managing complex conditions including subarachnoid hemorrhage (SAH).To quantify SAH volume-outcome association and determine the extent to which this is influenced by aggressiveness of care.A serial cross-sectional retrospective study using Nationwide Inpatient Sample for 2002 2010 was performed. Included were all adult (older 18 years age) discharged patients with a primary diagnosis admitted from emergency department or...

10.1227/neu.0000000000000850 article EN Neurosurgery 2015-06-24

<h3>BACKGROUND AND PURPOSE:</h3> Spinal dural arteriovenous fistulas are a rare entity that, if left untreated, can lead to considerable morbidity with progressive spinal cord symptoms. The aim of this study was evaluate the clinical outcome patients that were primarily treated endovascular embolization. <h3>MATERIALS METHODS:</h3> A retrospective review performed all from 1997–2010 who underwent treatment at 2 academic referral centers for fistula. Follow-up by examination, and functional...

10.3174/ajnr.a3522 article EN cc-by American Journal of Neuroradiology 2013-04-25

This study's purpose was to improve understanding of the forces driving complex mechanical interaction between embolic material and current stroke thrombectomy devices by analyzing histological composition strength emboli retrieved from patients evaluating necessary for retrieval such in a middle cerebral artery (MCA) bifurcation model.

10.3171/2019.12.jns192187 article EN Journal of neurosurgery 2020-03-06

CSP in patients with HNC presenting CBS can provide immediate hemostasis to prevent exsanguination. We evaluated the safety and efficacy of control acute life-threatening hemorrhage CBS.We retrospectively reviewed 10 (7 men, 3 women; mean age, 59 years) from that was treated CSP. studied patient demographics, presentations, procedures, initial delayed complications, technical clinical outcomes on follow-up.All achieved following Periprocedural complications consisted groin hematomas (n=2),...

10.3174/ajnr.a2379 article EN cc-by American Journal of Neuroradiology 2011-03-24

Herceptin (trastuzumab) is a human monoclonal antibody that interferes with the HER2 receptor. It currently only FDA-approved therapeutic for HER2-positive breast cancer. This article will present mechanism at action as well clinical role this antibody.

10.3174/ajnr.a2619 article EN cc-by American Journal of Neuroradiology 2011-08-04

Background Clopidogrel bisulfate and aspirin are routinely administered as dual antiplatelet agents for many neurointerventional procedures, especially intravascular stent placement. Many patients non-responsive to clopidogrel, either secondary drug interactions or from variations of cytochrome P450 enzymes. Prasugrel (brand name Effient, Eli Lilly Company, Indianapolis, IN, USA) is a new agent that has been utilized extensively in undergoing cardiovascular procedures but its safety efficacy...

10.1136/neurintsurg-2012-010302 article EN Journal of NeuroInterventional Surgery 2012-05-22
Coming Soon ...